Copying and distributing are prohibited without permission of the publisher.

Watermark

Simcere Pharma kicks off $461m Hong Kong IPO

biopharma_stocks_adobe_575x375.jpg
By Jonathan Breen
13 Oct 2020

Simcere Pharmaceutical Group has begun its Hong Kong listing, opening books for the up-to HK$3.57bn ($460.6m) deal.

Already a subscriber?

Continue reading this article

Try full access to GlobalCapital

Free Trial
By Jonathan Breen
13 Oct 2020